VOYA Investment Management’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
337,501
+222,012
+192% +$839K ﹤0.01% 1451
2026
Q1
$482K Buy
115,489
+104,814
+982% +$443K ﹤0.01% 1727
2025
Q4
$29.4K Hold
10,675
– – ﹤0.01% 2381
2025
Q3
$36.6K Sell
10,675
-5,871
-35% -$21.4K ﹤0.01% 2407
2025
Q2
$56.9K Buy
16,546
+1,129
+7% +$2.98K ﹤0.01% 2579
2025
Q1
$32.8K Sell
15,417
-876
-5% -$2.63K ﹤0.01% 2586
2024
Q4
$52K Sell
16,293
-812
-5% -$6.63K ﹤0.01% 2678
2024
Q3
$228K Buy
17,105
+1,236
+8% +$16.4K ﹤0.01% 2415
2024
Q2
$158K Buy
+15,869
New +$229K ﹤0.01% 2546

Other funds holding CATX

VOYA Investment Management's CATX Position: Q2 2026 in Review

VOYA Investment Management increased its Perspective Therapeutics (CATX) stake by 192% in Q2 2026, buying an estimated $839K and bringing the position to 337,501 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

VOYA Investment Management first reported a position in CATX in Q2 2024 and has held it in 9 quarters since. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • VOYA Investment Management held 337,501 shares of Perspective Therapeutics worth $1.15M as of Q2 2026.
  • VOYA Investment Management bought 222,012 Perspective Therapeutics shares in Q2 2026, an estimated $839K.
  • Perspective Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1451 holding.
  • VOYA Investment Management first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.